
Could a novel psychedelic treat alcohol use disorder?
A novel psychedelic compound, combined with psychological support, will be explored as a potential new treatment for people living with alcohol use disorder (AUD) in a Phase IIa study. The trial uses Beckley Psytech’s lead candidate BPL-003, a short-duration and fast-acting synthetic formulation of psychedelic mebufotenin… Read More


